Minerva Neurosciences Statistics
Want to see NERV full AI Analyst Report?
Minerva Neurosciences (NERV) Stock Statistics & Valuation Metrics
Total Valuation
Minerva Neurosciences has a market cap or net worth of $115.55M. The enterprise value is $246.79M.
- Market Cap
- $115.55M
- Enterprise Value
- $246.79M
Share Statistics
Minerva Neurosciences has 47,747,560 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 47,747,560
- Owned by Insiders
- 1.00%
- Owned by Institutions
- 15.05%
Financial Efficiency
Minerva Neurosciences’s return on equity (ROE) is 2.08 and return on invested capital (ROIC) is -15.79%.
- Return on Equity (ROE)
- 2.08
- Return on Assets (ROA)
- -3.00
- Return on Invested Capital (ROIC)
- -15.79%
- Return on Capital Employed (ROCE)
- -0.16
- Revenue Per Employee
- 0
- Profits Per Employee
- -41.92M
- Employee Count
- 7
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Minerva Neurosciences is -0.10. Minerva Neurosciences’s PEG ratio is 0.00.
- PE Ratio
- -0.10
- PS Ratio
- 0.00
- PB Ratio
- -0.00
- Price to FCF
- -4.00
- Price to Operating Cash Flow
- -4.13
- PEG Ratio
- 0.00
Income Statement
In the last 12 months, Minerva Neurosciences had revenue of 0 and earned -293.42M in profits. Earnings per share was -34.67.
- Revenue
- 0
- Gross Profit
- 0
- Operating Income
- -15.10M
- Pretax Income
- -293.42M
- Net Income
- -293.42M
- EBITDA
- -293.42M
- Earnings Per Share (EPS)
- -34.67
Cash Flow
In the last 12 months, operating cash flow was -31.40M and capital expenditures 0, giving a free cash flow of -31.40M billion.
- Operating Cash Flow
- -31.40M
- Free Cash Flow
- -31.40M
- Free Cash Flow per Share
- -0.64
Dividends & Yields
Minerva Neurosciences pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -24.96%
- Earnings Yield
- -227.85%
Stock Price Statistics
- Beta
- 1.39
- 52-Week Price Change
- -33.52%
- 50-Day Moving Average
- 3.22
- 200-Day Moving Average
- 4.88
- Relative Strength Index (RSI)
- 41.77
- Average Volume (3m)
- 196.61K
Important Dates
Minerva Neurosciences upcoming earnings date is ―, TBA (Confirmed).
- Last Earnings Date
- Aug 07, 2026
- Next Earnings Date
- ―
- Ex-Dividend Date
- ―
Financial Position
Minerva Neurosciences as a current ratio of 36.29, with Debt / Equity ratio of -46.15%
- Current Ratio
- 36.29
- Quick Ratio
- 36.29
- Debt to Market Cap
- 1.91
- Net Debt to EBITDA
- 0.06
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Minerva Neurosciences has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Minerva Neurosciences EV to EBITDA ratio is -0.26, with an EV/FCF ratio of -3.36.
- EV to Sales
- 0.00
- EV to EBITDA
- -0.26
- EV to Free Cash Flow
- -3.36
- EV to Operating Cash Flow
- -3.36
Balance Sheet
Minerva Neurosciences has $76.94M in cash and marketable securities with $0.00 in debt, giving a net cash position of $76.94M billion.
- Cash & Marketable Securities
- $76.94M
- Total Debt
- $0.00
- Net Cash
- $76.94M
- Net Cash Per Share
- $1.61
- Tangible Book Value Per Share
- -$2.04
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Minerva Neurosciences is $8.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- $8.50
- Price Target Upside
- 251.24% Upside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 2
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- -1306.84%
Scores
- Smart Score
- 4
- AI Score
- 42
